Axim Biotechnologies Inc (AXIM)

[BesaoT35]

Thanks Tex and mc73.

They never explained why the DED tests number declined in the last quarter. Could it have been a manufacturing issue that limited available supply of tests rather than a steep decline in demand? That would be an important distinction to be able to discern.

I remember seeing in the last 10-Q that the company is projected to achieve break even around the end of 2024. That is 3 1/2 months from now. Is this remotely likely or even possible? And if this is not possible is it legal for AXIM to make a statement to that effect? Did I read that correctly?

The Parkinson’s Disease test could have a large market that is substantially bigger than DED. I was excited to hear about that development. Early diagnosis might be a useful thing for PD patients to perhaps make preventative lifestyle changes early in the course of their disease. Would IR or the CEO be willing to discuss what is going on with this PD test and other tests in development?

Oftentimes a Biotech company will discuss such things to keep investors as optimistic as possible without abusively stretching the truth or pumping.

Can shareholders demand some sort of timely updates? Investors need to have more detailed information to make sound investment decisions.

CLIA waiver efforts are also not clear to me. This is fundamental to the success of the company.

Perhaps there could be an opportunity to double down at a cheap stock price below this stock price or wait a longer time until break even and an end to the massive dilution. Does anybody have any hope left for AXIM?